RESEARCH

Do healthcare professionals and patients provide the same kind of information when reporting the same adverse event?

Analysis of paired reports from the Norwegian ADR Registry suggests merging consumer and healthcare professional accounts of the same adverse event may improve causality assessment

19 August 2026

Safe by perception, risky in practice? What vitamin B6 and turmeric teach us about complementary medicines

Complementary medicines are widely used and often perceived as safe, yet high doses, product stacking, and unclear labelling can quietly increase the risk of harm.

07 April 2026

Pharmacovigilance of a high-risk drug: Can AI save us?

An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.

30 March 2026

Underreporting in pharmacovigilance: Where do we go from here?

While underreporting remains a persistent global challenge, innovative approaches are showing promise in different regions

18 February 2026